Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

Blood. 2002 Sep 15;100(6):2272-3. doi: 10.1182/blood-2002-06-1674.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Humans
  • Incidence
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Venous Thrombosis / chemically induced*
  • Venous Thrombosis / pathology

Substances

  • Thalidomide
  • Dexamethasone